上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Tubulin inhibitor 25
Tubulin inhibitor 25 是一种有效的微管蛋白 (tubulin) 抑制剂,IC50 为 0.98 μM。Tubulin inhibitor 25 对 HT29 细胞有显著的抑制作用。Tubulin inhibitor 25 能抑制细胞迁移和微管形成,有助于抗血管生成。
Tubulin inhibitor 25 Chemical Structure
CAS No. : 2411697-71-5
规格 |
|
是否有货 |
|
100 mg |
|
询价 |
|
250 mg |
|
询价 |
|
500 mg |
|
询价 |
|
* Please select Quantity before adding items.
生物活性 |
Tubulin inhibitor 25 is a potent tubulin inhibitor with an IC50 value of 0.98 μM. Tubulin inhibitor 25 exhibits remarkable activity against cancer cell line HT29. Tubulin inhibitor 25 displays the potent inhibition on cell migration and tube formation that contributes to the anti-angiogenesis[1].
|
IC50 & Target |
IC50: 0.98 μM (tubulin)[1]
|
体外研究 (In Vitro) |
Tubulin inhibitor 25 (compound 6c) (0-100 μM; 48 hours) exhibits high antiproliferative activity against tested cancer cell lines[1]. Tubulin inhibitor 25 (0-200 μM; 48 hours) exhibits low cytotoxicity in normal cell lines[1]. Tubulin inhibitor 25 (0.05, 0.1 and 0.2 μM; 24 hours) inhibits the colony formation of HT29 cells in a dose-dependent manner[1]. Tubulin inhibitor 25 (2 and 4 μM) can inhibit the tubulin polymerization and compete with colchicine binding site[1]. Tubulin inhibitor 25 (0.25-1 μM; 12-48 hours) arrests the cell cycle at G2/M phase and induces HT29 cells apoptosis in a dose- and time-dependent manner, besides induces HT29 cell depolarized mitochondria in the process of apoptosis[1]. Tubulin inhibitor 25 (0.25-1 μM; 24 hours) increases the expression of P21 and Cyclin B1 and decreases the expression of Cdc2, p-CDC2 and p-Cdc25c; as well as induces the microtubule collapse in HT29 cells in a dose-dependent manner[1]. Tubulin inhibitor 25 (0.01, 0.02 and 0.04 μM; 6 hours) effectively inhibits the HUVEC tube formation in a dose-dependent manner[1]. Tubulin inhibitor 25 (0.1, 0.2 and 0.4 μM; 24 hours) inhibits migration of A549 cells in a dose-dependent manner[1].
Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay
Cell Line: |
MDA-MB-231, HepG2, HT29, HCT116 and A549[1] |
Concentration: |
0-100 μM |
Incubation Time: |
48 hours |
Result: |
Exhibited high antiproliferative activity against HT29, HCT116, MDA-MB-231 and A549 with IC50s of 0.18 ± 0.04 μM, 0.58 ± 0.11 μM, 0.81 ± 0.13 μM and 0.57 ± 0.79 μM, and less activity against HepG2 with an IC50 of 73.20 ± 4.03 μM. |
Cell Cytotoxicity Assay
Cell Line: |
293T and LO2[1] |
Concentration: |
0-200 μM |
Incubation Time: |
48 hours |
Result: |
Exhibited low cytotoxicity in normal cell lines with CC50s of 184.86 ± 9.88 μM and 154.76 ± 9.98 μM in 293T and LO2. |
Cell Cycle Analysis
Cell Line: |
HT29[1] |
Concentration: |
0.25, 0.5 and 1 μM |
Incubation Time: |
12, 24, 36 and 48 hours |
Result: |
Arrested the cell cycle at G2/M phase in a dose-dependent manner with the G2/M cell proportion of 23.05%, 23.55% and 80.99% at 0.25 μM, 0.5 μM and 1 μM, respectively, also exhibited time-dependent manner with the G2/M cell proportion of 32.55%, 36.43% and 71.1% for 12, 36 and 48 hours. |
Western Blot Analysis
Cell Line: |
HT29[1] |
Concentration: |
0.25, 0.5 and 1 μM |
Incubation Time: |
24 hours |
Result: |
Increased the expression of P21 and Cyclin B1 and decreased the expression of Cdc2, p-CDC2 and p-Cdc25c. |
|
体内研究 (In Vivo) |
Tubulin inhibitor 25 (1.5 mg/kg; IV; single) exhibits good metabolic stability[1]. Pharmacokinetic Parameters of Tubulin inhibitor 25 in male Sprague-Dawley rats[1].
|
IV (1.5 mg/kg) |
T1/2 (h) |
3.81 ± 2.14 |
MRT0-∞ (h) |
5.12 ± 2.86 |
AUC0-∞ (ng/mL·h) |
2156.12 ± 851.88 |
VZ (L/kg) |
3.348 ± 0.734 |
Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: |
SD rats[1] |
Dosage: |
1.5 mg/kg |
Administration: |
IV; single (Pharmacokinetic Analysis) |
Result: |
Exhibited good metabolic stability. |
|
分子量 |
|
Formula |
|
CAS 号 |
|
运输条件 |
Room temperature in continental US; may vary elsewhere.
|
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务